These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7293730)

  • 1. Duchenne muscular dystrophy. Morphological study of erythrocytes after treatment with L-alpha-lysophosphatidyl-choline in dystrophic patients and in the carrier state.
    Dellantonio R; Capriotti M; Angeleri F; Curatola G; Mazzanti L; Bertoli E; Lenaz G
    Acta Neurol Belg; 1981; 81(4):193-8. PubMed ID: 7293730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erythrocyte membrane in Duchenne muscular dystrophy. I. Sensitivity to lysolecithin in dystrophic patients and their families].
    Grilli G; Bravi S; Angeleri F; Colombi A
    Boll Soc Ital Biol Sper; 1980 Dec; 56(23):2399-402. PubMed ID: 7470282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Echinogenic action of L-alpha-lysophosphatidylcholine in Duchenne muscular dystrophy: a study on carrier detection.
    Tangorra A; Curatola G; Milani-Comparetti M; Ferretti G
    Am J Med Genet; 1989 Apr; 32(4):540-4. PubMed ID: 2774000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological variations of erythrocytes in Duchenne muscular dystrophy and in carrier state.
    Capriotti M; Dellantonio R; Angeleri F; Curatola G; Mazzanti L; Bertoli E; Lenaz G; Leporoni B
    Boll Soc Ital Biol Sper; 1980 Jul; 56(14):1459-64. PubMed ID: 7448043
    [No Abstract]   [Full Text] [Related]  

  • 5. Progressive muscular dystrophy type Duchenne. II. Viscosity and resistence to erythrolytic compounds of erythrocyte membranes.
    Capriotti M; Dellantonio R; Di Bella P; Angeleri F; Bertoli E; Curatola G; Lenaz G
    Boll Soc Ital Biol Sper; 1979 Jun; 55(11):1028-32. PubMed ID: 549581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Morphology and deformability of erythrocytes in muscular dystrophy].
    Garceau C; Leblond PF; Lyonnais J; Beaupré A
    Nouv Rev Fr Hematol (1978); 1979 Jan; 20(4):585-98. PubMed ID: 375191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood myoglobin in children with progressive muscular dystrophy and in carriers].
    Calandi C; Baretti S; Pacciani G; Bagni P; Borsotti M; Tozzi P; Adami Lami C
    Quad Sclavo Diagn; 1984 Dec; 20(4):391-8. PubMed ID: 6537549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electron spin resonance studies of erythrocytes from patients with Duchenne muscular dystrophy.
    Sato B; Nishikida K; Samuels LT; Tyler FH
    J Clin Invest; 1978 Feb; 61(2):251-9. PubMed ID: 23391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of erythrocyte membranes to treatment with L-alpha-lysophosphatidylcholine in Duchenne muscular dystrophy.
    Tangorra A; Curatola G; Milani Comparetti M; Ferretti G
    Boll Soc Ital Biol Sper; 1988 May; 64(5):477-84. PubMed ID: 3179030
    [No Abstract]   [Full Text] [Related]  

  • 10. [Morphology and deformability of erythrocytes in muscular dystrophy].
    Garceau C; Leblond PF; Lyonnais J; Beaupré A
    Nouv Rev Fr Hematol (1978); 1978; 20(4):585-98. PubMed ID: 377225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipoproteins in Duchenne muscular dystrophy.
    Arthur H; de Niese M; Jeffrey PL; Austin L
    Biochem Int; 1983 Mar; 6(3):307-13. PubMed ID: 6679326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carrier detection in Duchenne muscular dystrophy.
    Roses AD; Roses MJ; Miller SE; Hull KL; Appel SH
    N Engl J Med; 1976 Jan; 294(4):193-8. PubMed ID: 1244534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discriminant analysis of ribosomal protein synthesis findings in carrier detection of Duchenne muscular dystrophy.
    Ionasescu V; Burmeister L; Hanson J
    Am J Med Genet; 1980; 5(1):5-12. PubMed ID: 7395900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Erythrocyte membrane in Duchenne muscular dystrophy. II. Fluidity of lipids in dystrophic patients and their families].
    Zolese G; Campagnoli P; Colombi A; Mazzanti L
    Boll Soc Ital Biol Sper; 1980 Dec; 56(23):2403-7. PubMed ID: 6258613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of propranolol and ouabain on ATP in erythrocytes from healthy adults and patients with Duchenne muscular dystrophy (author's transl)].
    Igisu H
    Fukuoka Igaku Zasshi; 1979 Jul; 70(7):361-9. PubMed ID: 478426
    [No Abstract]   [Full Text] [Related]  

  • 16. Cysteine and metalloproteinase activities in serum of Duchenne muscular dystrophic genotypes.
    Sohar I; Laszlo A; Gaal K; Mechler F
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():277-9. PubMed ID: 3202967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocyte shape in Duchenne muscular dystrophy.
    Matheson DW; Engel WK; Derrer EC
    Neurology; 1976 Dec; 26(12):1182-3. PubMed ID: 1033489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration in erythrocyte membrane structure in Duchenne muscular dystrophy.
    Wakayama Y; Hodson A; Pleasure D; Bonilla E; Schotland DL
    Ann Neurol; 1978 Sep; 4(3):253-6. PubMed ID: 718137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum myoglobin in muscular dystrophy.
    Kagen LJ; Moussavi S; Miller SL; Tsairis P
    Muscle Nerve; 1980; 3(3):221-6. PubMed ID: 7374673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electron spin resonance spin label studies of the erythrocyte membrane in Duchenne muscular dystrophy.
    Clark AD; Nash GB; Patel KJ; Wyard SJ
    Am J Med Genet; 1983 Oct; 16(2):153-61. PubMed ID: 6316786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.